Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Simvastatin (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 13
» View herald-mail.com items only
    Nov 26, 2012 |Story| Los Angeles Times
  1. Grapefruit doesn't mix well with some drugs, researchers remind

    It’s been known for a long time that eating grapefruit and taking certain prescription oral medications — including the cholesterol drugs atorvastatin, lovastatin and simvastatin as well as some cancer and heart drugs — don’t mix. 
    Los Angeles Times
    It’s been known for a long time that eating grapefruit and taking certain prescription oral medications — including the cholesterol drugs atorvastatin, lovastatin and simvastatin as well as some cancer and heart drugs — don’t mix. ...

    Tags: Chemical Industry, Science and Technology, Prescription Drugs, Pharmaceuticals, Statins (drugs)

  2. Sep 5, 2012 |Story| Chicago Tribune
  3. Study finds evidence that statins can lower the risk of some cancers

    That statin pill you take each day to keep your cholesterol in check may reduce your risk of cancer, too, according to a study in Israel.
    That statin pill you take each day to keep your cholesterol in check may reduce your risk of cancer, too, according to a study in Israel. The study examined data collected from 202,648 adults, ages 21 and older, who were enrolled in an HMO from 1998 to...

    Tags: Lymphoma, Statins (drugs), Leukemia, Tel Aviv (Israel), Lymphatic System

  4. Oct 7, 2011 |Story| WPIX-LTV
  5. FDA Approves Combination Therapy Juvisync For Type 2 Diabetes

    The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin...

    Tags: Chemical Industry, Drugs and Medicines, Heart Disease, Pharmaceuticals, Hormones and Metabolism

  6. May 26, 2011 |Story| Reuters
  7. |Story
  8. May 26, 2011 |Story| Chicago Breaking Business
  9. |Story
  10. May 27, 2011 |Story| Chicago Breaking Business
  11. |Story
  12. May 26, 2011 |Story| Chicago Tribune
  13. |Story
  14. Nov 30, 2009 |Story| Los Angeles Times
  15. Every drug has risks and information is key to avoiding them

    Some drugs are so common that consumers -- at their peril -- don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. We offer a few details on five of the most-prescribed medications. Hydrocodone with...

    Tags: Potassium (dietary supplement), Drugs and Medicines, Health, Pharmaceuticals, National or Ethnic Minorities

  16. Nov 30, 2009 |Story| Los Angeles Times
  17. Even the most common medications pose threats

    Some drugs are so common that consumers -- at their peril -- don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. To highlight these risks, we offer up a few details on five of the most-prescribed medications, with additional input from pharmacists interviewed for this package of stories.
    Some drugs are so common that consumers -- at their peril -- don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. To highlight these risks, we offer up a few details on five of the most-prescribed...

    Tags: Potassium (dietary supplement), Pain, Drugs and Medicines, Swelling, Urine

  18. Nov 30, 2009 |Story| Los Angeles Times
  19. PREVIOUS CONTENT: Common medications pose threats

    Some drugs are so common that consumers - at their peril - don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. To highlight these risks, we offer up a few details on five of the most-prescribed medications, with additional input from pharmacists interviewed for this package of stories.
    For Tribune Newspapers
    Some drugs are so common that consumers - at their peril - don't think twice about them. But each drug, whether prescription or over-the-counter, poses risks. To highlight these risks, we offer up a few details on five of the most-prescribed medications,...

    Tags: Potassium (dietary supplement), Pain, Drugs and Medicines, Swelling, Urine

  20. Nov 15, 2009 | Los Angeles Times
  21. Vytorin trial shows little or no benefit against heart disease [Updated]

    Booster Shots
    For the second time in as many years, a large clinical trial has found that the key ingredient in the heavily advertised drug Vytorin provides little or no benefit in preventing heart disease compared to a competing product. The ingredient......
  22. Dec 24, 2009 | Los Angeles Times
  23. FDA panel says Vytorin and Zetia probably don't cause cancer

    Booster Shots
    A comprehensive review of previous studies involving the cholesterol-lowering drugs Vytorin and Zetia and two large ongoing studies shows that "it is unlikely that [they] increase the risk of cancer or cancer-related deaths," a Food and Drug...
 1  2Next >
Original site for Simvastatin (drug) topic gallery.